TMCI:NASDAQ
Treace Medical Concepts, Inc
US$4.44
arrow_upward
+0.45%(+0.020) 1D
ኖቬም 17, 4:00:01 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
US$4.44
High
US$4.63
Low
US$4.37
Mkt. cap
291.08 ሚ
Avg. vol.
305.25 ሺ
Volume
0.00
52-wk high
US$5.43
52-wk low
US$1.17
EPS
-US$0.86
Beta
1.59
Shares outstanding
65.56 ሚ
No. of employees
450
Open
US$4.44
High
US$4.63
Low
US$4.37
Mkt. cap
291.08 ሚ
Avg. vol.
305.25 ሺ
Volume
0.00
52-wk high
US$5.43
52-wk low
US$1.17
EPS
-US$0.86
Beta
1.59
Shares outstanding
65.56 ሚ
No. of employees
450
News stories
From web sources and news partners
Trefis
·
ከ51 ደቂቃዎች በፊት
9 S&P 500 Stocks Just Made New 52-Week Lows
Benzinga
·
ከ1 ሰዓት በፊት
Stock Market: Will S&P 500 Open Up or Down Today?
Latest news from Azerbaijan
·
ከ38 ደቂቃዎች በፊት
Dow, S&P 500, Nasdaq futures extend losses for fourth session amid AI sell-off
Traders Union
·
ከ6 ሰዓቶች በፊት
S&P 500 rises 10 percent amid challenging backdrop, Nate Geraci notes
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc